Related Experiment Video
Updated: Feb 15, 2026
05:39
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
714
Lupus miliaris disseminatus faciei.
Helena Toda-Brito1, João Manuel Pires Aranha1, Ermelindo Silva Tavares1
1Department of Dermatology, Santarém Hospital, Santarém, Portugal.
Anais Brasileiros De Dermatologia
|January 25, 2018
Summary
Lupus miliaris disseminatus faciei, a rare facial rash, typically resolves on its own but can cause scarring. This case study highlights successful treatment with minocycline and steroids.
Area of Science:
- Dermatology
- Pathology
- Immunology
Background:
- Lupus miliaris disseminatus faciei (LMDF) is a rare inflammatory skin condition of unknown cause.
- It primarily affects young adults, presenting as asymptomatic facial papules, often around the eyelids.
Observation:
- Histopathology reveals epithelioid granulomas with central necrosis and giant cells.
- The condition is known for its potential to cause cosmetic disfigurement and scarring.
Findings:
- A case of LMDF was successfully treated with a combination of minocycline and systemic steroids.
- This suggests a potential therapeutic option for this challenging condition.
Implications:
- Further controlled studies are needed to establish definitive treatment protocols for LMDF.
- Understanding the therapeutic efficacy of antibiotics and corticosteroids may guide future management strategies.
